| Next 10 |
Business Wire News Releases and Press Releases
Business Wire news releases, related news releases, and press releases on the OTC, NASDAQ and NYSE markets.
-
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DouYu International Holdings Limited (NASDAQ: DOYU) pursuant and/or traceable to DouYu’s July 16, 2019 initial public offering (the “IPO” or the “Offering”) of the imp...
-
Global Games Industry Encourages Players to Follow Health and Safety Guidelines for COVID-19; Provides Information and Social Connection Zynga (NASDAQ:ZNGA): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200328005018/en...
-
Companies leverage expertise to breathe new life into machines in fight against coronavirus Bloom Energy Corp. (NYSE: BE) and Almo Corporation today announced they are joining forces to refurbish unused, out-of-warranty ventilators and ship them to state agencies and hospitals througho...
-
Phase 3 VICTORIA Trial is the First Contemporary Outcomes Study Focused Exclusively on a Chronic Heart Failure Patient Population Following a Worsening Event Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of results from the VICTO...
-
New data showed consistent effect of FARXIGA in patients with heart failure with reduced ejection fraction, regardless of background therapy New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showe...
-
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of ProPetro Holding Corp. (“ProPetro” or the “Company”) (NYSE: PUMP ) concerning whether the board breached its fiduciary duties to shareholders. If you are a s...
-
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Mesa Air Group, Inc. (“Mesa” or “the Company”) (NASDAQ: MESA ) for violations of the securities laws. The investigation fo...
-
The Law Offices of Frank R. Cruz announces an investigation on behalf of Mesa Air Group, Inc. ("Mesa" or the Company") (NASDAQ: MESA ) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss,...
-
Masonite International Corporation (NYSE: DOOR) today announced business updates related to novel coronavirus (COVID-19). In recent weeks we have seen the impacts of COVID-19 grow both domestically and abroad. Accordingly, the company has taken actions to both protect its employees and fo...
-
In an effort to further improve its financial position and liquidity in light of the uncertainty regarding the potential length and severity of the COVID-19 pandemic and its corresponding impact on its business, Tilly’s Inc. (NYSE: TLYS) (the “Company”) today announced th...
Now Trending
Trending Stock
31.57%Change Percent:
CytoDyn Inc Company Name:
CYDY Stock Symbol:
OTC Market:
cytodyn.com Website:
MENU
CYDY Stock
CYDY Quote
CYDY Short
CYDY News
CYDY Articles
CYDY Message Board
Get CYDY Stock Alerts
News, Short Squeeze, Breakout and More Instantly...
RECENT CYDY NEWS
-
The respiratory condition that is so dangerous in Covid-19 results from a condition called a "cytokine storm." CytoDyn (CYDY) believes that filling the CCR5 receptor with a harmless monoclonal body will prevent further damage. CytoDyn reported on March 19 that its main drug candidate, lero...
-
Sanofi (NASDAQ: SNY ) and Translate Bio (NASDAQ: TBIO ) add an mRNA vaccine for COVID-19 to their 2018 collaboration aimed at developing vaccines for infectious diseases. TBIO has begun producing multiple mRNA constructs and will use its mRNA platform to design and manufacture a range of c...
-
VANCOUVER, Washington, March 27, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announce...
